Clinical trial
Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver…
NCT00171743 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00171743 |
|---|---|
| Title | Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients |
| Official title | Switch From Tacrolimus to Cyclosporine Microemulsion: Immunosuppressive Agents and Diabetes Management in Liver Transplant Recipients in Maintenance (DIALIVER) |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Liver Transplant |
| Intervention type | Drug |
| Interventions | Cyclosporine microemulsion |
| Enrollment | 47 |
| Start date | Apr 1, 2004 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Jun 7, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: